| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | $6.8B | $6.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $8.6B | $7.9B | $1.9B | $1.2B | $5.4B | $4.6B | $1.1B | $0.9B |
| Net Income | $5.0B | $4.5B | $2.8B | $2.5B | $3.9B | $1.4B | $3.7B | $0.5B |
| EPS (Basic) | $6.31 | $5.71 | $1.27 | $-0.86 | $4.94 | — | — | $0.65 |
| EPS (Diluted) | $6.31 | $5.71 | $1.27 | $-0.86 | $4.94 | — | — | $0.65 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $195.7B | $186.3B | $176.9B | $178.1B | $169.6B | $162.4B | $158.8B | $145.4B |
| Current Assets | $11.6B | $12.9B | $12.8B | $13.2B | $9.9B | $8.7B | $9.2B | $9.7B |
| Cash & Equivalents | $0.2B | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $21.0B | $19.4B | $17.3B | $18.9B | $15.9B | $16.3B | $14.8B | $15.0B |
| Stockholders' Equity | $51.8B | $50.1B | $49.1B | $49.3B | $49.3B | $48.0B | $46.8B | $43.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $12.3B | $12.3B | $9.9B | $5.9B | $8.3B | $8.9B | $8.2B | $7.2B |
| Investing Cash Flow | $-14.3B | $-13.1B | $-12.5B | $-12.0B | $-10.9B | $-10.6B | $-12.0B | $-10.1B |
| Capital Expenditures | $14.0B | $12.3B | $12.6B | $11.4B | $9.7B | $9.9B | $11.1B | $9.4B |
| Financing Cash Flow | $1.9B | $0.9B | $2.4B | $6.1B | $2.6B | $1.7B | $3.7B | $3.0B |